Daily Business Update from the Boston Globe

To ensure you receive your Boston.com e-mails, please add newsletters@boston.com to your address book. If you have trouble reading this e-mail, go to http://www.boston.com/business/ticker_headlines
Get up-to-the-minute Globe Business Updates   |  More Business News
	ADVERTISEMENT Monday, September 20, 2010 Campanelli tapped for Hingham project Campanelli Cos. said it has been selected by A.W. Perry to help develop of Two Pond Park Medical Center in Hingham. Boston ranks 13th in business Twitter use A survey that examined Twitter use by business people found that Boston ranked 13th among US cities for business tweeting. Good Start Genetics repays loan Good Start Genetics Inc. is the first company to repay an accelerator loan from the Massachusetts Life Sciences Center, the center said today. Chiofaro revises plan for waterfront project Developer Donald J. Chiofaro today unveiled his latest revision of the Harbor Garage redevelopment, proposing a pair of angular towers reaching 470 feet and 615 feet, respectively. Who, What, Where A sample of personnel announcements from local companies. FDA to consider approval of modified salmon A Massachusetts company is asking the Food and Drug Administration to approve the marketing of genetically engineered salmon, which would become the first such animal OK'd for human consumption. Economic panel says recession ended in June 2009 It's official: The longest recession the country has endured since World War II ended in June 2009, according to a group that dates the beginning and end of recessions. Genzyme says Synvisc approved in Japan CAMBRIDGE -- Genzyme Corp. said its drug Synvisc, which treats osteoarthritis of the knee, has been approved in Japan. Local gas prices remain at $2.609 a gallon The average price for gas in Massachusetts held steady at $2.609 a gallon in the latest weekly survey from AAA, AAA Southern New England said today. Boston Scientific agrees to buy asthma company Boston Scientific Corp., the Natick medical device company, said today that it has agreed to buy cquire Asthmatx Inc., a privately held California company specializing in asthma treatments. IBM to buy Netezza for $1.7 billion Technology giant IBM said this morning that it plans to pay about $1.7 billion to buy Netezza Corp., a Marlborough company that sells hardware and software that helps big companies run their data warehouses. Aeris gets a regulatory OK Aeris Therapeutics said it has been given regulatory approval to move forward with commercialization of its AeriSeal System in Europe. Today in Globe Business A sample of Business stories from today's Globe.